Citations (48)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Yue-Ming Wang, Sergio C Chai, Christopher T Brewer & Taosheng Chen. (2014) Pregnane X receptor and drug-induced liver injury. Expert Opinion on Drug Metabolism & Toxicology 10:11, pages 1521-1532.
Read now
Read now
Yue-Ming Wang, Su Sien Ong, Sergio C Chai & Taosheng Chen. (2012) Role of CAR and PXR in xenobiotic sensing and metabolism. Expert Opinion on Drug Metabolism & Toxicology 8:7, pages 803-817.
Read now
Read now
Katherine S. Fenner, Hannah M. Jones, Mohammed Ullah, Sarah Kempshall, Maurice Dickins, Yurong Lai, Paul Morgan & Hugh A. Barton. (2012) The evolution of the OATP hepatic uptake transport protein family in DMPK sciences: from obscure liver transporters to key determinants of hepatobiliary clearance. Xenobiotica 42:1, pages 28-45.
Read now
Read now
Anne T Nies & Matthias Schwab. (2010) Organic cation transporter pharmacogenomics and drug–drug interaction. Expert Review of Clinical Pharmacology 3:6, pages 707-711.
Read now
Read now
P. Annaert, Z.W. Ye, B. Stieger & P. Augustijns. (2010) Interaction of HIV protease inhibitors with OATP1B1, 1B3, and 2B1. Xenobiotica 40:3, pages 163-176.
Read now
Read now
Margherita Strolin Benedetti, Rhys Whomsley, Italo Poggesi, Willi Cawello, François-Xavier Mathy, Marie-Laure Delporte, Peggy Papeleu & Jean-Baptiste Watelet. (2009) Drug metabolism and pharmacokinetics. Drug Metabolism Reviews 41:3, pages 344-390.
Read now
Read now
Articles from other publishers (42)
Leonida Rakateli, Rosanna Huchzermeier & Emiel P. C. van der Vorst. (2023) AhR, PXR and CAR: From Xenobiotic Receptors to Metabolic Sensors. Cells 12:23, pages 2752.
Crossref
Crossref
Xiaomei Wu, Bin Pang, Jianwei You, Leiye Yu, Ruobing Ren, Hongyang Wang & Li Chen. (2023) An LC-MS-based workflow measures the export activity of S1P transporters. Biochemical and Biophysical Research Communications 668, pages 118-124.
Crossref
Crossref
Jingyuan Wang, Peipei Lu & Wen Xie. (2023) Atypical functions of xenobiotic receptors in lipid and glucose metabolism. Medical Review 2:6, pages 611-624.
Crossref
Crossref
Xiaocui Li, Xiaowen Ou, Guangkuo Luo, Xiaojun Ou, Yushan Xie, Mengdi Ying, Wei Qu, Huilin Zuo, Xiaoxiao Qi, Ying Wang, Zhongqiu Liu & Lijun Zhu. (2020) Mdr1a, Bcrp and Mrp2 regulate the efficacy and toxicity of mesaconitine and hypaconitine by altering their tissue accumulation and in vivo residence. Toxicology and Applied Pharmacology 409, pages 115332.
Crossref
Crossref
K. Darney, L. Turco, F.M. Buratti, E. Di Consiglio, S. Vichi, A.C. Roudot, C. Béchaux, E. Testai, J.L.C.M. Dorne & L.S. Lautz. (2020) Human variability in influx and efflux transporters in relation to uncertainty factors for chemical risk assessment. Food and Chemical Toxicology 140, pages 111305.
Crossref
Crossref
Jin-jun Wu, Zhen-zhen Guo, Yuan-feng Zhu, Zhi-jian Huang, Xia Gong, Yu-huan Li, Wen-jie Son, Xiao-yan Li, Yan-mei Lou, Li-jun Zhu, Lin-lin Lu, Zhong-qiu Liu & Liang Liu. (2018) A systematic review of pharmacokinetic studies on herbal drug Fuzi : Implications for Fuzi as personalized medicine. Phytomedicine 44, pages 187-203.
Crossref
Crossref
Qing Li, Zhi Ye, Peng Zhu, Dong Guo, Hong Yang, Jin Huang, Wei Zhang, James E. Polli & Yan Shu. (2018) Indinavir Alters the Pharmacokinetics of Lamivudine Partially via Inhibition of Multidrug and Toxin Extrusion Protein 1 (MATE1). Pharmaceutical Research 35:1.
Crossref
Crossref
Meiyi Li, Chen Li, Wei-Xin Liu, Conghui Liu, Jingru Cui, Qingrun Li, Hong Ni, Yingcheng Yang, Chaochao Wu, Chunlei Chen, Xing Zhen, Tao Zeng, Mujun Zhao, Lei Chen, Jiarui Wu, Rong Zeng & Luonan Chen. (2017) Dysfunction of PLA2G6 and CYP2C44-associated network signals imminent carcinogenesis from chronic inflammation to hepatocellular carcinoma. Journal of Molecular Cell Biology 9:6, pages 489-503.
Crossref
Crossref
P. Lu & W. Xie. 2017. Drug Metabolism in Diseases. Drug Metabolism in Diseases
257
278
.
Dmitriy S. Titov & S. K Pravkin. (2016) The effectiveness and safety of pharmacotherapy against the background of application of Gliquidone. Medical Journal of the Russian Federation 22:4, pages 203-206.
Crossref
Crossref
Q. Li, H. Yang, D. Guo, T. Zhang, J. E. Polli, H. Zhou & Y. Shu. (2016) Effect of Ondansetron on Metformin Pharmacokinetics and Response in Healthy Subjects. Drug Metabolism and Disposition 44:4, pages 489-494.
Crossref
Crossref
D S Titov & L V Nikiforova. (2015) EFFECT OF AN INHIBITOR OF DPP-4-VTLDAGLIPTIN FOR THE FUNCTIONAL ACTIVITY OF P-GLYCOPROTEIN IN VIVO. I.P. Pavlov Russian Medical Biological Herald 23:3, pages 54-60.
Crossref
Crossref
Filippo Ingoglia, Rossana Visigalli, Bianca Maria Rotoli, Amelia Barilli, Benedetta Riccardi, Paola Puccini & Valeria Dall'Asta. (2015) Functional characterization of the organic cation transporters (OCTs) in human airway pulmonary epithelial cells. Biochimica et Biophysica Acta (BBA) - Biomembranes 1848:7, pages 1563-1572.
Crossref
Crossref
Wen-Hao Yu, Na Zhang, Jin-Feng Qi, Chen Sun, Yong-Hui Wang & Mei Lin. (2015)
Arsenic and Mercury Containing Traditional Chinese Medicine (Realgar and Cinnabar) Strongly Inhibit Organic Anion Transporters, Oat1 and Oat3,
In Vivo
in Mice
. BioMed Research International 2015, pages 1-7.
Crossref
Crossref
Pavel M. Vassiliev, Alexander A. Spasov, Vadim A. Kosolapov, Aida F. Kucheryavenko, Nataliya A. Gurova & Vera A. Anisimova. 2014. Application of Computational Techniques in Pharmacy and Medicine. Application of Computational Techniques in Pharmacy and Medicine
369
431
.
Laurent P. Rivory. 2014. Handbook of Anticancer Pharmacokinetics and Pharmacodynamics. Handbook of Anticancer Pharmacokinetics and Pharmacodynamics
351
371
.
Douglas B. Kell. (2013) Finding novel pharmaceuticals in the systems biology era using multiple effective drug targets, phenotypic screening and knowledge of transporters: where drug discovery went wrong and how to fix it. FEBS Journal 280:23, pages 5957-5980.
Crossref
Crossref
Qing Li, Dong Guo, Zhongqi Dong, Wei Zhang, Lei Zhang, Shiew-Mei Huang, James E. Polli & Yan Shu. (2013) Ondansetron can enhance cisplatin-induced nephrotoxicity via inhibition of multiple toxin and extrusion proteins (MATEs). Toxicology and Applied Pharmacology 273:1, pages 100-109.
Crossref
Crossref
Paul ZarogoulidisKaid Darwiche, Wolfgang Hohenforst-Schmidt, Haidong Huang, Qiang Li, Lutz Freitag & Konstantinos Zarogoulidis. (2013) Inhaled gene therapy in lung cancer: proof-of-concept for nano-oncology and nanobiotechnology in the management of lung cancer. Future Oncology 9:8, pages 1171-1194.
Crossref
Crossref
Liangfu Chen & Joseph W. Polli. 2013. Pharmacogenomics of Human Drug Transporters. Pharmacogenomics of Human Drug Transporters
13
37
.
Xiaofeng Bao, Shuiyu Lu, Jeih-San Liow, Cheryl L. Morse, Kacey B. Anderson, Sami S. Zoghbi, Robert B. Innis & Victor W. Pike. (2012) [11C]Rhodamine-123: Synthesis and biodistribution in rodents. Nuclear Medicine and Biology 39:8, pages 1128-1136.
Crossref
Crossref
Alexander V. LyubimovKevin Beaumont. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
26
.
V. Hutter, C. Hilgendorf, A. Cooper, V. Zann, D.I. Pritchard & C. Bosquillon. (2012) Evaluation of layers of the rat airway epithelial cell line RL-65 for permeability screening of inhaled drug candidates. European Journal of Pharmaceutical Sciences 47:2, pages 481-489.
Crossref
Crossref
Manali Mukherjee, D.I. Pritchard & C. Bosquillon. (2012) Evaluation of air-interfaced Calu-3 cell layers for investigation of inhaled drug interactions with organic cation transporters in vitro. International Journal of Pharmaceutics 426:1-2, pages 7-14.
Crossref
Crossref
J.P. Keogh. 2012. Current Concepts in Drug Metabolism and Toxicology. Current Concepts in Drug Metabolism and Toxicology
1
42
.
Elena Dolghih, Clifford Bryant, Adam R. Renslo & Matthew P. Jacobson. (2011) Predicting Binding to P-Glycoprotein by Flexible Receptor Docking. PLoS Computational Biology 7:6, pages e1002083.
Crossref
Crossref
Maisa N. Feghali & Donald R. Mattison. (2011) Clinical Therapeutics in Pregnancy. Journal of Biomedicine and Biotechnology 2011, pages 1-13.
Crossref
Crossref
Anne T. Nies, Hermann Koepsell, Katja Damme & Matthias Schwab. 2011. Drug Transporters. Drug Transporters
105
167
.
Masahiro Sakagami & Mark Gumbleton. 2011. Controlled Pulmonary Drug Delivery. Controlled Pulmonary Drug Delivery
127
141
.
Thomas N. Thompson. 2011. Pharmacokinetics in Drug Development. Pharmacokinetics in Drug Development
285
313
.
Xiaowan Zheng & James Polli. (2010) Identification of inhibitor concentrations to efficiently screen and measure inhibition Ki values against solute carrier transporters. European Journal of Pharmaceutical Sciences 41:1, pages 43-52.
Crossref
Crossref
Cynthia Bosquillon. (2010) Drug transporters in the lung—do they play a role in the biopharmaceutics of inhaled drugs?. Journal of Pharmaceutical Sciences 99:5, pages 2240-2255.
Crossref
Crossref
Michael D. Coleman. 2010. Human Drug Metabolism. Human Drug Metabolism
319
327
.
Kimberly K. Adkison, Soniya S. Vaidya, Daniel Y. Lee, Seok Hwee Koo, Linghui Li, Amar A. Mehta, Annette S. Gross, Joseph W. Polli, Joan E. Humphreys, Yu Lou & Edmund J.D. Lee. (2010) Oral Sulfasalazine as a Clinical BCRP Probe Substrate: Pharmacokinetic Effects of Genetic Variation (C421A) and Pantoprazole Coadministration. Journal of Pharmaceutical Sciences 99:2, pages 1046-1062.
Crossref
Crossref
J.B. WatkinsIIIIII & C.D. Klaassen. 2010. Comprehensive Toxicology. Comprehensive Toxicology
77
91
.
Vasiliki Panagiotopoulou, Giles Richardson, Oliver E. Jensen & Cyril Rauch. (2009) On a biophysical and mathematical model of Pgp-mediated multidrug resistance: understanding the “space–time” dimension of MDR. European Biophysics Journal 39:2, pages 201-211.
Crossref
Crossref
Ragini Vuppugalla, Sean Kim, Tatyana Zvyaga, Yong-hae Han, Praveen Balimane, Punit Marathe & A. David Rodrigues. 2010. Enzyme- and Transporter-Based Drug-Drug Interactions. Enzyme- and Transporter-Based Drug-Drug Interactions
585
624
.
Tonika Bohnert & Liang‐Shang Gan. 2009. Enzyme Inhibition in Drug Discovery and Development. Enzyme Inhibition in Drug Discovery and Development
91
176
.
Mathew G. SoarsPeter J. H. WebbornRobert J. Riley. (2009) Impact of Hepatic Uptake Transporters on Pharmacokinetics and Drug−Drug Interactions: Use of Assays and Models for Decision Making in the Pharmaceutical Industry. Molecular Pharmaceutics 6:6, pages 1662-1677.
Crossref
Crossref
Hui-Po Wang & Chun-Li Wang. (2009) Biological Transporters as Targets for New Drug Design. Journal of Experimental & Clinical Medicine 1:1, pages 31-38.
Crossref
Crossref
Christopher Kohl. (2009) Transporters – The View from Industry. Chemistry & Biodiversity 6:11, pages 1988-1999.
Crossref
Crossref
Samantha L. Forster, Steve R. Hood & Nick J. Plant. (2009) In Silico Modelling of Drug Fate and Disposition. Toxicology 262:1, pages 3-4.
Crossref
Crossref